Search Results - "ENOH, S"

The Impact of Gastroesophageal Reflux and Esophageal Motility on Spirometry Following Lung Transplantation by Fessler, L.N., Mathew, J., Bazemore, K., Bush, E., Agbor-Enoh, S., Shah, P.D.

“…Although lung transplant recipients (LTR) with uncorrected gastroesophageal reflux disease (GERD) have been shown to have increased allograft complications,…”
Get full text

Outcomes of ISHLT Lung Transplant AMR by Cochrane, A.B., Levine, D., Ponor, I., Philogene, M., Jang, M., Tunc, I., Mathew, J., Luikart, H., Shah, P., Khush, K., Marboe, C., Berry, G., Valentine, H., Agbor-Enoh, S.

“…ISHLT published diagnostic criteria for AMR in 2016 delineating the diagnostic certainty of AMR with definite, probable, and possible grading that considers…”
Get full text

De Novo Mutations in Mitochondrial DNA of iPSCs Produce Immunogenic Neoepitopes in Humans by Gravina, A., Deuse, T., Hu, X., Agbor-Enoh, S., Koch, M., Alawi, M., Marishta, A., Peters, B., Wang, D., Valantine, H., Weissman, I., Schrepfer, S.

“…Autologous induced pluripotent stem cells (iPSC)-based therapies are considered to be promising in the transplantation field, however their immunological…”
Get full text

Characterization of Respiratory Pathogens in Contemporary Lung Transplant Recipients by Bazemore, K., Permpalung, N., Rohly, M., Timofte, I., Brown, A., Orens, J., Iacono, A., Nathan, S., Avery, R., Valentine, H., Agbor-Enoh, S., Shah, P.

“…This study assessed respiratory pathogens isolated in the first year post lung transplant in a recent multicenter cohort. Prior studies may not reflect current…”
Get full text

The Effect of the Cystic Fibrosis Care Center on Lung Transplant Outcomes by Krishnan, A., Bush, E.L., Chidi, A., Nolley, E., Agbor-Enoh, S., West, N.E., Tallarico, E., Orens, J.B., Ha, J., Shah, P., Segev, D., Massie, A., Higgins, R.S., Merlo, C.A.

“…Since 1961 the Cystic Fibrosis Foundation has designated certain institutions devoted to treating cystic fibrosis (CF) as Cystic Fibrosis Care Centers (CFCC)…”
Get full text

Early and Late Pulmonary AMR Show Distinct Profiles; Clinical and Epigenetic Analyses by Agbor-Enoh, S., Jang, M., Singh, K., Tunc, I., Pirooznia, M., Seifuddin, F., Ponor, I., Levine, D., Cochrane, A., Philogene, M., Mathews, J., Shah, P., Luikart, H., Khush, K.K., Marboe, C., Berry, G., Valantine, H.

“…Antibody-Mediated Rejection (AMR) that occurs latter in the lung transplant (LTx) course show greater risk of chronic lung allograft dysfunction (CLAD) than…”
Get full text

Novel Inhibitor of Plasmodium Histone Deacetylase That Cures P. berghei-Infected Mice by Agbor-Enoh, S, Seudieu, C, Davidson, E, Dritschilo, A, Jung, M

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Allograft Injury and Outcomes in African American Lung Transplant Recipients by Agbor-Enoh, S., Charya, A., Jang, M., Luikart, H., Shah, P., Matthews, J., Brown, A.W., Timofte, I., Fideli, U., Kong, H., Bhatti, K., Marishta, A., Yang, Y., Tunc, I., Berry, G., Marboe, C., Iacono, A., Nathan, S., Khush, K., Orens, J.B., Valantine, H.

“…African American patients (AA) have poorer outcomes than White patients (W) after heart and kidney transplant. Little is known about differential outcomes in…”
Get full text

Clinical Outcomes after Pediatric Lung Transplantation at Cystic Fibrosis Care Centers by Chidi, A.P., Krishnan, A., Nolley, E., Agbor-Enoh, S., West, N.E., Tallarico, E., Thaxton, A., Orens, J.B., Ha, J., Shah, P.D., Segev, D., Massie, A., Higgins, R.S., Merlo, C.A., Bush, E.L.

“…Clinical outcomes remain extremely poor for children with cystic fibrosis undergoing lung transplantation. Since 1961, the Cystic Fibrosis Foundation has…”
Get full text

Donor-Derived-Cell-Free DNA to Identify Primary Graft Dysfunction Patients at Risk of Chronic Lung Allograft Dysfunction by Keller, M.B., Shah, P., Bush, E., Diamond, J.M., Matthews, J., Brown, A.W., Timofte, I., Fideli, U.S., Kong, H., Marishta, A., Bhatti, K., Yang, Y., Tunc, I., Luikart, H., Berry, G., Marboe, C., Iacono, A., Nathan, S., Khush, K.K., Orens, J., Jang, M., Valentine, H.A., Agbor-Enoh, S.

“…Primary Graft Dysfunction (PGD) is a risk factor for Chronic Lung Allograft Dysfunction (CLAD). However, this association requires further examination for…”
Get full text

Improved Survival after Repeat Lung Transplantation at Cystic Fibrosis Care Centers by Chidi, A.P., Krishnan, A., Nolley, E., Agbor-Enoh, S., West, N.E., Tallarico, E., Thaxton, A., Orens, J.B., Ha, J.S., Shah, P.D., Segev, D., Massie, A., Higgins, R.S., Merlo, C.A., Bush, E.L.

“…Patients who undergo repeat lung transplantation (LT) are at high risk for perioperative complications. The complexity of their care requires specialized…”
Get full text

Lung Transplantation: DSA to AMR Trajectory by Ponor, I., Levine, D., Cochrane, A., Philogene, M.C., Shah, P.D., Mathew, J., Brown, A.W., Timofte, I., Fideli, U., Kong, H., Marishta, A., Yang, Y., Tunc, I., Luikart, H., Berry, G., Marboe, C., Iacono, A., Nathan, S., Khush, K.K., Orens, J., Jang, M., Valentine, H., Agbor-Enoh, S.

“…Donor specific antibodies(DSA) are a major risk factor for antibody mediated rejection (AMR) and allograft failure in lung transplant recipients (LTs). The…”
Get full text

Association between Pretransplant Antibody against Angiotensin II Type 1 Receptor and Posttransplant Allograft Injury by Philogene, M., Massie, A.B., Kong, H., Shah, P., Cochrane, A., Ponor, I., Levine, D., Shah, K.B., Hsu, S., Feller, E.D., Rodrigo, M.E., Najjar, S.S., Tunc, I., Berry, G., Marboe, C., Jang, M., Agbor-Enoh, S., Valantine, H.

“…In heart transplantation (HT), antibodies directed against Angiotensin II type 1 receptor (AT1RAb) have been associated with antibody-mediated rejection (AMR),…”
Get full text

To Treat or Not to Treat: DSA Positive Lung Transplant Recipients by Agbor-Enoh, S., Ponor, I., Shah, P., Levine, D., Cochrane, A., Philogene, M., Matthews, J., Brown, A.W., Timofte, I., Fideli, U., Kong, H., Marishta, A., Bhatti, K., Tunc, I., Yang, Y., Luikart, H., Marboe, C., Berry, G., Iacono, A., Nathan, S., Khush, K.K., Orens, J., Jang, M., Valantine, H.

“…Donor-specific antibodies (DSA) is a major risk factor for chronic lung allograft dysfunction (CLAD) after lung transplantation (LTx). Unfortunately, DSA…”
Get full text

Lung Transplant Recipients with Severe Primary Graft Dysfunction Requiring ECMO Had Similar Donor-Derived Cell-Free DNA Levels and Lung Function as Matched Controls by Timofte, I., Iacono, A., Terrin, M., Vesselinov, R., Bhatti, K., Marishta, A., Young, C., Pervaiz, A., Fideli, U., Tunc, I., Kwesiga, D.M., Orens, J., Shah, P., Nathan, S.D., Brown, A.W., Valantine, H.A., Agbor-Enoh, S.

“…Extracorporeal Membrane Oxygenation (ECMO) is a lifesaving procedure in lung transplant recipients with severe primary graft dysfunction (PGD). There is…”
Get full text

Early Donor-Derived Cell-Free DNA Predicts Peak Allograft Function in Heart Transplant by Brusca, S.B., Jang, M.K., Shah, P., Shah, K.B., Hsu, S., Feller, E.D., E, M., Najjar, S.S., Fideli, U.S., Kong, H., Marishta, A., Bhatti, K., Yang, Y., Tunc, I., Solomon, M.A., Berry, G., Marboe, C., Agbor-Enoh, S., Valantine, H.A.

“…Donor-derived cell-free DNA (ddcfDNA) is a validated marker of allograft injury in heart transplant, predicting both acute cellular (ACR) and antibody mediated…”
Get full text

Increased Cell Free DNA Levels in African American Patients Early after Heart Transplantation by Doshi, A.H., Tushak, Z., Kong, H., Garcia, V., Jang, M.K., Shah, P., Hsu, S., Feller, E.D., Rodrigo, M.E., Najjar, S.S., Fideli, U.S., Marishta, A., Bhatti, K., Yang, Y., Tunc, I., Solomon, M.A., Berry, G., Marboe, C., Agbor-Enoh, S., Shah, K.B., Valantine, H.A.

“…African American (AA) patients are at risk for increased rates of rejection after heart transplantation (HT). We compared cell-free DNA (cf-DNA) levels after…”
Get full text

Urine Cell-Free Donor-Derived DNA (ucfdDNA) after Heart Transplantation by Agbor-Enoh, S, Doveikis, J, Zhu, J, Tunc, i, Wang, X, Jackson, A, Solomon, M, Valantine, H

Get full text

The Association between Donor-Recipient Race Matching and Survival Following Lung Transplantation Differs Based on Recipient Race by Evans, C.F, Sanchez, P.G, Kon, Z.N, Wang, X, Valantine, H, Agbor-Enoh, S, Iacono, A.T, Griffith, B.P, Pham, S.M

Get full text

Early Graft Injury Measured by Donor-Derived Cell-Free DNA Predicts Early Mortality in Lung Transplant Recipients by Agbor-Enoh, S, Tunc, I, De Vlaminck, I, Davis, A, Gorham, S, Jang, M, Cuttin, K, Fideli, U, Marishta, A, Wylie, J, Luikart, H, Khush, K, Valantine, H

Get full text